Pancreatic ductal adenocarcinoma (PDAC) is predominantly driven by oncogenic KRAS signaling and sustained by a desmoplastic, immunosuppressive microenvironment limiting therapeutic response. CD73-mediated adenosine signaling supports this immune-excluded, tumor-supportive microenvironment. Whether dual targeting of KRA...
Khadija Turabi, Urvinder Kaur Sardarni, Katherine E. Ankenbauer et al.· bioRxiv· 0 citations
Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy, with a five-year survival rate near 10%. The rarity of PDAC contrasts the abundance of its primary precursor lesion, pancreatic intraepithelial neoplasia (PanIN). PanIN is known to be common in surgically resected pancreas and to exist even in normal don...
Valentina Matos-Romero, Kara A. Lombardo, Daniela Higuera-Garrido et al.· Cancer Research· 0 citations
Perineural invasion (PNI), the infiltration of nerves by tumor cells, is a hallmark of pancreatic ductal adenocarcinoma (PDAC); however, despite being a clinically relevant phenomenon, the mechanisms underlying PNI remain poorly understood. Most currently available in vitro and ex vivo models rely on murine-sourced n...
Regina A. Casimiro-Núñez, Sydney Willey, Harrison L. Hiraki et al.· Cancer Research· 0 citations
Pan-RAS inhibition remodels the pancreatic immune microenvironment resulting in diminished CD8+ T cell effector abundance and functionality, as a potential consequence of systemic pan-RAS inhibition.
Rashmi J. Kumar, E. Lasse-Opsahl, Lauren Gerbereux et al.· Cancer Research· 0 citations
Notch is a contact-dependent signaling pathway that plays critical roles in spatiotemporal patterning during embryogenesis. Beyond its role in development, Notch signaling regulates tissue patterning in adult organs in response to tissue injury or cancer. In the context of cancer, the role of Notch signaling has been...
Allison C. Bischoff, Wei Yan, Carlos E. Espinoza et al.· Cancer Research· 0 citations
This work investigated how KMT2D loss rewires enhancer accessibility and transcription factor networks to promote EMP in PDAC and identified an important mechanism underlying the tumor suppressive role of KMT2D in PDAC.
Raghunath Ranga Sudharshan, H. Kim, Heizel Acosta et al.· Cancer Research· 0 citations
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive type of pancreatic cancer classically driven by oncogenic KRAS mutations. It is thought to arise from precursor lesions including intraductal papillary mucinous neoplasia (IPMN) and pancreatic intraepithelial neoplasia (PanIN). We have recently reported that Pa...
J. Okoye, Rosina Carr, Carlos E. Espinoza et al.· Cancer Research· 0 citations
It is suggested that pharmacologic and genetic KRAS inhibition differentially remodel the intratumoral T cell compartment, whereas both induce similar T cell changes within the liver premetastatic niche.
Lauren Gerbereux, Rashmi Kumar, E. Lasse-Opsahl et al.· Cancer Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.